The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Trinity Translational Medicine Institute (TTMI) (https://www.tcd.ie/ttmi/) is TCD large-scale centre of knowledge excellence supporting patient-orientated research. Its close proximity with St. James’s hospital and Clinical Research facilities makes of TTMI the suitable space where to take on translational biomedical research. TTMI includes over 40 Principal Investigators and 150 scientists, and Translational Cancer is one of its main research themes. TTMI offers high-quality expertise in the cancer field. It hosts in fact various labs that are part of the Trinity St James’s Cancer Institute, which is a member of the Organisation of European Cancer Institutes (the 1st in Ireland).
Cell biology\Immunology\Lung cancer\Molecular biology\Smoking
Global fellowships (return phase only)\ European fellowships
TTMI offers unique facilities (https://www.tcd.ie/ttmi/facilities/) in translational lung-cancer research, from conventional and advanced (e.g. organoids, lung-on-chip) cellular-based approaches to in vivo animal models and patient-orientated research:
LBCAM is extremely well funded through a wide range of international funding agencies, including European Union FP7 and H2020 and Science Foundation Ireland funding programmes. TTMI is working closely with St. James’s Hospital and the Wellcome Trust-HRB funded Clinical Research Facility to establish a COVID-19 patient registry and biobank (St. James’s TCD Allied Research (STAR) Collaboration for COVID-19).
TTMI has a strong programme for industry engagement to support advances in medical research to directly benefit patients, with a wealth of experience developing enterprise collaborations. TTMI is well placed to advise and capitalise on various national and international support initiatives. TTMI liaises closely with organisations such as IPPOSI, the Irish Platform for Patients Organisations, Science and Industry, set up to facilitate the co-operation between patients’ organisations, scientists, clinicians, regulators and industry to stimulate the development of devices, therapies and diagnostics. TTMI is also connected to the Health Innovation Hub Ireland as a leading location for healthcare start-ups and companies.
TTMI focuses on the key principles of excellence and training. TTMI runs a structured seminar series where scientists and clinicians from different disciplines present their translational work. This forum stimulates interactions across the different thematic areas within the institute and also allows for the development of collaborations between different disciplines. Also, TTMI liaises with the Trinity Biomedical Sciences Institute, the Trinity College Institute of Neurosciences, and the Centre for
Research on Adaptive Nanostructures and Nanodevices as well as large research and training programmes, such as TILDA, AMBER, the Global Brain Health Initiative and the Wellcome HRB Clinical Research Facility at St. James’s Hospital. TTMI has developed a unique career mentoring programme for its research fellows, where they are mentored on all aspects of career development activities by senior faculty within the institute. TTMI participates in “Science Week” and disease awareness months, to disseminate the translational work within the Institute.
In the process of applying